COVID-19 in persons with multiple sclerosis treated with ocrelizumab - A pharmacovigilance case series

被引：49
|
作者：
Hughes, Richard [1 ]
Pedotti, Rosetta [1 ]
Koendgen, Harold [1 ]
机构：
[1] F Hoffmann La Roche Ltd, Basel, Switzerland
来源：
MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2020年 / 42卷
关键词：
D O I：
10.1016/j.msard.2020.102192
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Fast but not furious: rapid ocrelizumab infusion for Multiple Sclerosis patients' management during COVID-19 pandemic
    Zanetta, C.
    Bucca, C.
    Nozzolillo, A.
    Guerrieri, S.
    Rocca, M.
    Moiola, L.
    Filippi, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 476 - 476
  • [42] Ocrelizumab extended dosing in Primary Progressive Multiple Sclerosis during the COVID-19 pandemic: a multicenter experience
    D'Amico, E.
    Avolio, C.
    Lus, G.
    Bonavita, S.
    Ferraro, D.
    Callari, G.
    Barone, S.
    Patti, F.
    Granella, F.
    Zanghi, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 1007 - 1008
  • [43] Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic
    Ghajarzadeh, Mahsa
    Mirmosayyeb, Omid
    Barzegar, Mahdi
    Nehzat, Nasim
    Vaheb, Saeed
    Shaygannejad, Vahid
    Maghzi, Amir-Hadi
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 43
  • [44] Parvovirus B19 infection in a patient with multiple sclerosis treated with ocrelizumab
    Lattanzi, Simona
    Carlini, Giulia
    Acciarri, Maria Cristina
    Danni, Maura
    Silvestrini, Mauro
    ACTA NEUROLOGICA BELGICA, 2020, 120 (01) : 231 - 232
  • [45] Parvovirus B19 infection in a patient with multiple sclerosis treated with ocrelizumab
    Simona Lattanzi
    Giulia Carlini
    Maria Cristina Acciarri
    Maura Danni
    Mauro Silvestrini
    Acta Neurologica Belgica, 2020, 120 : 231 - 232
  • [46] Multiple sclerosis patients and COVID-19
    Mado, Hubert
    Adamczyk-Sowa, Monika
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2021, 57 (01):
  • [47] Multiple sclerosis patients and COVID-19
    Hubert Mado
    Monika Adamczyk-Sowa
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 57
  • [48] Multiple sclerosis, rituximab, and COVID-19
    Langer-Gould, Annette
    Smith, Jessica B.
    Li, Bonnie H.
    Beaber, Brandon E.
    Brara, Sonu M.
    Debacker, Julie
    Nielsen, Allen Scott
    Amirova, Samira
    Ayeni, Oluwasheyi
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (04): : 938 - 943
  • [49] Experiences of persons with multiple sclerosis with the Covid-19 vaccination: A cross-sectional study of the Swiss Multiple Sclerosis Registry
    Stanikic, Mina
    Twomey, Eric
    Puhan, Milo A.
    Kamm, Christian P.
    Salmen, Anke
    Ajdacic-Gross, Vladeta
    Zecca, Chiara
    Gobbi, Claudio
    von Wyl, Viktor
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 74
  • [50] Exploring COVID-19 experiences for persons with multiple sclerosis and carers: An Australian qualitative study
    Correia, Helen
    Martin-Lynch, Pamela
    Finlayson, Marcia
    Learmonth, Yvonne C.
    HEALTH EXPECTATIONS, 2023, 26 (02) : 785 - 794
12345